MZN 
Vision becomes a product only through selection and validation.
Phase 3 decides which Zoyan to build first, which capabilities stay out of scope, which interaction architecture is feasible, how context is governed, and what pilot evidence is strong enough to justify the next step.
Build the smallest product that can prove the loop.
Product Scope
Choose the first user problem, primary journey and intentional exclusions.
Interaction / Device
Ring vs app vs hybrid; microphones/sensors; wake-word split; battery, latency, privacy and hardware requirements.
Context / Memory / Consent
What may be remembered, for what purpose, how long, how users correct/delete it, and how recency/confidence work.
Intelligence Architecture
Select models, routing, tools, memory, HUAI depth and evaluation criteria.
Trust / Safety / Security
Action permissions, confirmation, privacy, monitoring, failure handling and high-risk escalation.
Wellness Boundary
Keep clinical/diagnostic claims outside public scope until specialist, regulatory and device-classification review.
Bounded Pilot
Specific users and journeys, observable outcomes, error/failure logs, consent and measurable success/failure criteria.
Partnership / Distribution
Choose the counterparty that matches the selected product: hardware, AI/model, commerce, fashion, enterprise, security, distribution or investment.
The final architecture is not the v1 backlog.
The full Zoyan architecture can guide long-term coherence while the first product remains deliberately narrow. Phase 3 should avoid making every legacy feature, every MZN asset and every device ambition a launch dependency.
Personal operations first.
Calendar, reminders, task context, voice interaction and a small permissioned memory surface are a plausible bounded path.
Style-first Zoyan experience.
Use a narrow external service cluster when it improves the selected user journey rather than expanding Zoyan's core scope.
HUAI-integrated pilot.
Test whether provenance/confidence/context/routing materially improves a selected user journey before expanding integration.
What this Phase 3 page deliberately does not imply.
Historical deployment
Zoyan's earlier lineage does not mean a deployed Zoyan product existed in Phase 1.
Production hardware
The smart-ring direction does not establish production readiness, battery performance, sensor readiness or manufacturing validation.
Medical status
Zoyan is not presented here as a diagnostic system, treatment provider or certified medical device.
Full integration
The wider MZN portfolio is not claimed to be production-integrated inside Zoyan.
A Zoyan conversation can start at different layers.
Wearable & device partner
Ring feasibility, industrial design, audio/input architecture, battery, sensors, manufacturing and device ecosystem.
Intelligence partner
Models, inference, tool use, voice, on-device/cloud split, evaluation and selected HUAI integration.
Trust partner
Consent, retention, access controls, threat modeling, monitoring, audit and high-risk action boundaries.
Mazzaneh / market partner
Optional request, seller/service response, transaction and outcome loops.
Experience / service partner
Selected lifestyle, productivity, commerce or device services can connect without becoming the identity of Zoyan.
Strategic Phase 3 partner
Fund, distribute or co-build a defined Zoyan scope rather than entering the entire MZN portfolio by default.
Zoyan can have its own partner, budget, diligence scope, pilot and success criteria. Participation in other MZN Phase 3 programs is optional.
The next useful milestone is a v1 product definition.
Once the first user problem and interaction surface are selected, the architecture can be converted into a concrete PRD, technical dependency map, risk register, pilot protocol and partner brief.